ABOUT

Noblegen Inc. is an advanced bioproducts manufacturer dedicated to developing cost-effective, naturally-derived biomaterials and biochemicals for a wide range of consumer and industry sectors. We utilize a unique platform that combines proven industrial methods with our proprietary “directed expression” technique to commercially cultivate microorganisms. This platform allows for the development of cost-effective dietary, health and biochemical products. These products are inspired by a clear and simple vision – to make a meaningful difference by delivering inspired biological solutions for some of the world’s greatest problems.

We are an advanced biotechnology company that is focused on the generations of tomorrow and the environmental challenges of today. We want to create an avenue for a healthier, more balanced relationship between people and planet. To do so, the large-scale cost-effective production of our products is paramount for displacing existing unsustainable sources. We are positioned to be a leader in the biotechnology sector and introduce a new wave of advanced bioproducts.

our_story2

Ontario Centres of Excellence. Photography by Lucia Graca Remedios

OUR STORY

Noblegen originated out of CEO and Founder Adam Noble’s award winning research. Mr. Noble’s scientific work started as a high school science fair project and continued for several years while attention grew to how its application could positively impact the world. His groundbreaking research on a select microorganism and its novel capabilities won him several national and international awards and an invitation to accept the Dudley R. Herschbach Award at the Nobel Prize ceremonies in Stockholm, Sweden in 2012. To this day, Mr. Noble remains the highest awarded youth scientist in Canadian history.

Noblegen was created in 2013 when Adam Noble and Dr. Andressa Lacerda identified a promising opportunity to apply his award-winning research to industry. In the early years, Noblegen was known for a unique water technology that applied some of Mr. Noble’s early research. Our first major milestone came in 2015 with the completion of our industrial system which was a one million times scale version of the first lab prototype. Based on this work Mr. Noble was the youngest recipient of one of Canada’s 2014 Clean50 Awards, which recognizes outstanding work in sustainable development and cleantech, and was also named one of Canada’s Top 20 under 20, which recognizes exceptional leadership, innovation and achievement in youth.

In the last three years dedicated research and development has expanded applications for the technology to include nutrition, health and biochemicals. The development of our multi-product platform expanded our product offering and has allowed our company to remain agile in a capital intensive industry.

In the last three years dedicated research and development has expanded applications for the technology to include nutrition, health and biochemicals.

Technology Platform

At the core of the Noble business and overall strategy is our multi-product platform technology. We have developed a platform that combines our proprietary approach to production with the best proven fermentation techniques in industry. The result is a next generation technology that offers advanced outcomes while using a pragmatic and scalable design.

The foundation of our platform technology is our “directed expression” technique. With this technique we are able to control the characteristics of several of several copmonents of our organisms without genetic manipulation. We view each of our organisms as individual unicellular biofactories, capable of producing high-value compounds. This method allows us to dictate how the machinery inside each of these biofactories will work in order to generate target outputs naturally and efficiently. We are able to direct how our microorganisms manufacture compounds at the cellular level by adjusting key parameters in the production process. These critical adjustments enhance the natural mechanisms of our microorganisms to encourage rapid growth and the efficient conversion of varied low-value inputs into high-value compounds. These compounds are then processed and shipped to customers across several target markets. Our platform is an unprecedented advancement in the biotechnology sector, and is designed to outcompete existing platforms in efficiency, flexibility and cost-effectiveness.

At the core of the Noble business and overall strategy is our multi-product platform technology.
We’re a groundbreaking biomaterials company, meeting the world’s need for solutions that are sustainable, efficient and cost-effective.

INNOVATIVE BIOPRODUCTS
We’re a groundbreaking biomaterials company, meeting the world’s need for solutions that are sustainable, efficient and cost-effective. 

Utilizing a proprietary approach to microorganism cultivation, we create biomaterials and bio-chemicals with wide market applications.

SUSTAINABLE AND COST-EFFECTIVE
Utilizing a proprietary approach to microorganism cultivation, we create biomaterials and bio-chemicals with wide market applications. 

NobleGen is a unique single platform which represents a significant advancement for the biotechnology industry.

WHY WE’RE DIFFERENT
NobleGen is a unique single platform which represents a significant advancement for the biotechnology industry.

WHAT WE DO

Products and Markets

We currently offer several cost-competitive microorganism-derived products with applications across a range of markets. Our dietary, health and biochemical products offer customers alternative sources of cost-effective macronutrients and specialty micronutrients in addition to novel compounds and biochemicals.

NobleGen’s three core products – protein, oils and fibre – offer food and beverage companies a unique, non-GMO source of dietary ingredients

Food and beverage

NobleGen’s three core products – protein, oils and fibre – offer food and beverage companies a unique, non-GMO source of dietary ingredients that satisfy the demand of savvy, health-conscious consumers for products they can feel good about.

These products offer significant marketable advantages, both nutritionally and environmentally, over conventional plant and animal ingredient sources, which are limited in their growth efficiency and require immense resources for production.

Our microorganisms are more sustainably grown and can be consumed by customers across many market segments since they are also non-allergenic and vegetarian.

 

NobleGen’s omega oils, immune-modulating polymers, antioxidants and vitamins are derived from a sustainable source

Nutraceutical

NobleGen’s omega oils, immune-modulating polymers, antioxidants and vitamins are derived from a sustainable source and feature impressive chemical structures for optimal health benefits.

These ingredients offer nutraceutical companies the opportunity to differentiate their consumer products and to expand into growing specialty segments.

Our refined oils, antioxidants, vitamins, and minerals offer high-value ingredients for applications in cosmetics.

Cosmetics

Our refined oils, antioxidants, vitamins, and minerals offer high-value ingredients for applications in cosmetics. We reliably produce alternatively-sourced ingredients that can be integrated into mass market and luxury product formulations. Our ingredients are derived from an all-natural socially and environmentally responsible source, unlike other ingredient sources. Marine-derived ingredients, for example, are extracted from wild fish stocks currently in worldwide decline. These ingredients are subject to fluctuating commodity prices and environmental risk. Our products are a reliable, high quality alternative to conventional sources.

Livestock feed manufacturers are seeking new ingredients to differentiate their products and increase conversion ratios.

Animal Nutrition

The animal nutrition market is divided into companion animal and livestock applications. The companion animal segment continues to demand innovative ingredients which are healthy for pets and socially and environmentally responsible. The humanization of pets and the integration of human nutrition standards into the companion animal segment makes our protein-rich and oil-rich biomass products particularly valuable in the specialty food category. Simultaneously, the growing demand for dietary protein from land animals and aquaculture requires the increased production of land crops for feed. Livestock feed manufacturers are seeking new ingredients to differentiate their products and increase conversion ratios.

NobleGen develops water treatment solutions for industries ranging from greenhouse hydroponics to the agricultural, oil & gas and mining sectors.

Biochemicals

NobleGen develops water treatment solutions for industries ranging from greenhouse hydroponics to the agricultural, oil & gas and mining sectors.

Our patented bio-filtration water treatment technology can be customized to target specific contaminants and meets the need for sustainable water filtration methods that are clean, efficient, scalable and affordable.

Our platform amplifies the metabolic pathways of our microorganisms so their complex mechanisms can be fully exploited.

Pharmaceuticals

The future of human health is dependent upon smart medicine, and our products will be a solution to some of the most significant challenges facing the biopharmaceutical market. Our platform amplifies the metabolic pathways of our microorganisms so their complex mechanisms can be fully exploited. This is a distinguishing characteristic from yeast and bacteria, which have simple biological mechanisms that often require genetic modification for the production and commercialization of therapeutic compounds. Our microorganism cells will advance the biopharmaceutical market by providing an alternative to therapies developed using costly mammalian cells. The market potential for advanced biotherapeutics is substantial and our microorganisms will have a significant impact on the advancement of medicine.

OUR TEAM

Management Team

Our management team collectively boasting several decades of senior level management, engineering and research experience. With diverse skill sets and experience, the team is well balanced and leads the company with vision and purpose.

Adam Noble

Adam Noble

CEO & Founder
Adam has demonstrated his strong vision for Noblegen by scaling up his research to an industrial level, securing millions of dollars in private investment, and recruiting an impressive team of talented professionals.
Andressa Lacerda, Ph D.

Andressa Lacerda, Ph D.

Executive VP & Co-founder
With her impressive management and research background, Andressa has co-authored 6 publications and is a co-inventor on 2 US patents.
Eric Howe

Eric Howe

President
Eric has held several senior executive positions and offers substantial experience in international business development.
Ron Savoy , P. Eng

Ron Savoy , P. Eng

Chief Operating Officer
Ron brings over 16 years of management experience as well as an MBA and BSc in Engineering.

Board of Directors

Our BOD is currently comprised of two esteemed first-round investors, two experienced business professionals, and our Founder and CEO, Adam Noble, occupying the position as Chairman of the Board. With diverse backgrounds in finance, business development, engineering and research, our BOD plays a critical role in the leadership of the company.

The two board members that offer highly relevant experience for our commercialization strategy are Gwyn Morgan and David Paterson.

Adam Noble, Chair
Adam Noble is the CEO and founder of Noblegen.

Gwyn Morgan
Gwyn Morgan is the Founder and Retired CEO of Encana Corporation. He is a member of the Order of Canada (2010), and a highly decorated member of Canada’s corporate elite. He is the recipient of six honorary university degrees, and received the prestigious title of Canadian CEO of the Year in 2005. His experience in finance, business and market development make him an important asset to our BOD.

David M. Paterson
David Paterson is a retired senior executive at Johnson & Johnson. He spent more than 23 years with Johnson & Johnson’s Canadian divisions, and 5 years as head of global finance for J&J’s Advanced Sterilization Products group in California USA. Mr. Paterson is a Chartered Accountant and has worked in various executive, marketing and finance management positions. He brings expertise in strategy and new technology and market development to our BOD.

Kate Ramsay
A member of the Peterborough Regional Angel Network, Kate Ramsey brings a wealth of governance experience to the Board. Ms. Ramsey served on Trent University’s Board of Governors from 2011 to 2010, and has played governance and advocacy roles in the fields of education, agriculture, conservation, children’s mental health, victims of violence, the arts, and community policing.

John Desbiens, Board Member
John Desbiens is the President & CEO of Cambium Environmental, a professional engineering and consulting firm established since 2006, and holds leadership positions in several community organizations. His strong technical, communication, and organizational skills, and his specific experience in drinking water systems, water quality, and water quantity, make him an invaluable asset to Noblegen.

With diverse backgrounds in finance, business development, engineering and research, our BOD plays a critical role in the leadership of the company.

Ontario Centres of Excellence. Photography by Lucia Graca Remedios

NEWS

PRESS RELEASES

Adam Noble, CEO and Founder, Noblegen; Leo Groake, President, Trent University; Daryl Bennet, Mayor of Peterborough, ON

Right to Left: Adam Noble, CEO and Founder, Noblegen; Leo Groake, President, Trent University; Daryl Bennet, Mayor of Peterborough, ON

PARTNERS

OUR PARTNERS

Peterborough Community Futures Development Corporation
Ontario Centres of Excellence
Trent University
Fleming College
Greater Peterborough Innovation Cluster
NSERC
FedDev
Cambium Consulting and Engineering
Champlain-Animal-Hospital

CONTACT INFORMATION

CONTACT

Noblegen

DNA Building B101
2140 East Bank Drive
Peterborough, ON K9L 1Z8
Canada

705-748-1011 ext. 6268

 info@noblegen.com